FERMT2 and melanoma: kindlin-2 was identified as a candidate target from an siRNA library screen, and we found that in melanoma, kindlin-2 knockdown inhibited cell proliferation, promoted apoptosis, and suppressed growth and metastasis, while kindlin-2 overexpression resulted in the inverse effects.